Case Report
Spinal Analgesic Drug Delivery for Ehlers-Danlos Hypermobility Type Chronic Pain Treatment: A Case Report
Van Tilburg CWJ* | |
Consultant Anesthesiologist and Pain Specialist, Department of Anesthesiology, Bravis hospital, The Netherlands | |
*Corresponding Author : | Cornelis W. J. van Tilburg MD, FIPP, Consultant Anesthesiologist and Pain Specialist Multidisciplinary pain center, Department of Anesthesiology Bravis hospital, Boerhaaveplein 1, 4624 VT Bergen op Zoom, The Netherlands Tel: 0031-887067697 Fax: 0031 887067699 E-mail: vtilburg@ziggo.nl |
Received: January 17, 2016; Accepted: January 17, 2016; Published: February 26, 2016 | |
Citation: Van Tilburg CWJ (2016) Spinal Analgesic Drug Delivery for Ehlers-Danlos Hypermobility Type Chronic Pain Treatment: A Case Report. J Pain Relief 5:235. doi:10.4172/2167-0846.1000235 | |
Copyright: © 2016 Van Tilburg CWJ. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
Abstract
Study background: Chronic pain in patients with Ehlers-Danlos hypermobility type can be a severe, debilitating disorder. Scientific literature on pain treatment in these patients is scarce. We present a case report on spinal analgesic drug delivery for diminishing pain. Methods: Multidisciplinary consultation in adult female patient with Ehlers-Danlos, hypermobility type. Implanting Synchromed® II pump (Medtronic, Minneapolis, MN, United States of America) after successful trial period. One year follow-up. Results: During the trial period, verbal Numerical Rating Scale decreased from 8 to 3 with 0.72 mg of spinal morphine (2 mg/mL, 0.36 mL/day) and no oral or transdermal opioids. The spinal morphine/hydromorphone infusion schemes and verbal NRS for pain after implantation are presented. Baseline and follow-up results at one year from the other questionnaires are presented. Wound healing was successful. Conclusion: Spinal analgesic drug delivery can be an option to treat chronic, widespread pain in patients with Ehlers-Danlos syndrome, hypermobility type. Multidisciplinary consultation is necessary to deal with the wide variety of problems in these patients